The global legionella testing market size was estimated to be USD 263.1 million in 2023 and is expected to reach at USD 644.7 million by 2034 with a CAGR of 8.49% during the forecast period 2024-2034. Rising prevalence of Legionella-related disorders, growing awareness regarding preventive management, increasing geriatric population who is more prone to various diseases, surge in technological development in rapid testing kits, rising demand for rapid advanced diagnostic techniques, growing research & development activities, surge in government initiatives regarding the disease, and increasing launch of advanced legionella testing assays are some of the key factors boosting the market growth.
Increasing launch of advanced legionella testing assays is predicted to boost the market growth during the forecast period. Legionella bacteria have the potential to cause Legionellosis, a respiratory illness akin to pneumonia. Given its severity, it necessitates intensive medical care and hospitalization, making it a significant public health concern. As Legionella thrives in warm water environments, various industries reliant on water storage are susceptible to its presence in water systems. These waterborne bacteria pose a threat to places such as schools, restaurants, hospitals, and large plumbing systems. Consequently, there is a growing need in various industries for precise and timely Legionella diagnosis and the detection of related infections. For instance, in July 2023, DiaSorin has introduced the LIAISON Legionella Urinary Antigen Immunodiagnostic Assay in countries where the CE Mark is accepted. This assay is designed to assist in the diagnosis of Legionnaires' Disease (LD), which is a severe and potentially life-threatening form of atypical Community Acquired Pneumonia (CAP).
By type, water testing was the highest revenue-grossing segment in the global legionella testing market in 2023 owing to increasing government regulations require mandatory testing for Legionella, rising need for the development of new & advanced diagnostics tools, growing trend of diagnostic technological advancements particularly in terms of automation & digitization, and surge in initiatives by market players. For instance, in May 2022, ChemREADY, a leading provider of water and wastewater treatment chemicals, has unveiled a new program aimed at addressing Legionella, a water-borne pathogen, in building water systems. This program includes Legionella services and products as part of their efforts to combat this potential health threat. Additionally, IVD testing is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of chronic & infectious diseases, rising technological advancements in rapid test kits, and increasing demand for early disease diagnosis.
By end-user, microbial culture was the highest revenue-grossing segment in the global legionella testing market in 2023 owing to its high specificity, sensitivity, & accuracy in identifying Legionella bacteria and increasing launch of new tests by market players. For instance, in March 2022, IDEXX, a worldwide authority in water microbiology, has made an announcement regarding the publication of the Legiolert test for the rapid detection of Legionella pneumophila. This test has been officially recognized and published by ASTM International as "ASTM D8429-21: Standard Test Method for Legionella pneumophila in Water Samples Using Legiolert.". Additionally, PCR is predicted to grow at fastest CAGR during the forecast period owing to its various advantages including prompt & precise diagnoses, as well as consistently reproducible results and growing technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in awareness regarding Legionellosis disease among the general public with the environmental legionella isolation techniques Evaluation (ELITE) program, the presence of market players, increasing technological advancements, and rising collaborations within market players. For instance, in August 2022, Genomadix Inc, a company based in Canada, has revealed that it has forged an agreement with Mayo Clinic to improve its point-of-care portable PCR-based diagnostics system, known as CubeTM. This system is designed to provide results in approximately one hour. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing geriatric population who is more prone to infections, the widespread adoption of Legionella testing products is expanding through a global distribution network, rising awareness regarding accessible test products, and increasing regulations in testing legionella serogroups. For instance, in April 2022, China has introduced a new regulation called the General Code for Water Supply, Drainage, and Water Saving of Buildings (GB55020-2021), which is now in effect. This regulation was issued by the Chinese Ministry of Housing and Urban-Rural Development. Under this national legislation, building water systems must adhere to engineering standards and guidelines during their design, construction, and maintenance phases. Researchers at the Chinese Center for Disease Control and Prevention (CDC) are considering using the rqmicro method in future studies to establish distinct contamination levels for more precise management of Legionella risk. The recently launched rqmicro COUNT has proven to be a valuable technical tool for quantifying Legionella in various water matrices.
Increasing launch of advanced legionella testing assays is predicted to boost the market growth during the forecast period. Legionella bacteria have the potential to cause Legionellosis, a respiratory illness akin to pneumonia. Given its severity, it necessitates intensive medical care and hospitalization, making it a significant public health concern. As Legionella thrives in warm water environments, various industries reliant on water storage are susceptible to its presence in water systems. These waterborne bacteria pose a threat to places such as schools, restaurants, hospitals, and large plumbing systems. Consequently, there is a growing need in various industries for precise and timely Legionella diagnosis and the detection of related infections. For instance, in July 2023, DiaSorin has introduced the LIAISON Legionella Urinary Antigen Immunodiagnostic Assay in countries where the CE Mark is accepted. This assay is designed to assist in the diagnosis of Legionnaires' Disease (LD), which is a severe and potentially life-threatening form of atypical Community Acquired Pneumonia (CAP).
By type, water testing was the highest revenue-grossing segment in the global legionella testing market in 2023 owing to increasing government regulations require mandatory testing for Legionella, rising need for the development of new & advanced diagnostics tools, growing trend of diagnostic technological advancements particularly in terms of automation & digitization, and surge in initiatives by market players. For instance, in May 2022, ChemREADY, a leading provider of water and wastewater treatment chemicals, has unveiled a new program aimed at addressing Legionella, a water-borne pathogen, in building water systems. This program includes Legionella services and products as part of their efforts to combat this potential health threat. Additionally, IVD testing is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of chronic & infectious diseases, rising technological advancements in rapid test kits, and increasing demand for early disease diagnosis.
By end-user, microbial culture was the highest revenue-grossing segment in the global legionella testing market in 2023 owing to its high specificity, sensitivity, & accuracy in identifying Legionella bacteria and increasing launch of new tests by market players. For instance, in March 2022, IDEXX, a worldwide authority in water microbiology, has made an announcement regarding the publication of the Legiolert test for the rapid detection of Legionella pneumophila. This test has been officially recognized and published by ASTM International as "ASTM D8429-21: Standard Test Method for Legionella pneumophila in Water Samples Using Legiolert.". Additionally, PCR is predicted to grow at fastest CAGR during the forecast period owing to its various advantages including prompt & precise diagnoses, as well as consistently reproducible results and growing technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in awareness regarding Legionellosis disease among the general public with the environmental legionella isolation techniques Evaluation (ELITE) program, the presence of market players, increasing technological advancements, and rising collaborations within market players. For instance, in August 2022, Genomadix Inc, a company based in Canada, has revealed that it has forged an agreement with Mayo Clinic to improve its point-of-care portable PCR-based diagnostics system, known as CubeTM. This system is designed to provide results in approximately one hour. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing geriatric population who is more prone to infections, the widespread adoption of Legionella testing products is expanding through a global distribution network, rising awareness regarding accessible test products, and increasing regulations in testing legionella serogroups. For instance, in April 2022, China has introduced a new regulation called the General Code for Water Supply, Drainage, and Water Saving of Buildings (GB55020-2021), which is now in effect. This regulation was issued by the Chinese Ministry of Housing and Urban-Rural Development. Under this national legislation, building water systems must adhere to engineering standards and guidelines during their design, construction, and maintenance phases. Researchers at the Chinese Center for Disease Control and Prevention (CDC) are considering using the rqmicro method in future studies to establish distinct contamination levels for more precise management of Legionella risk. The recently launched rqmicro COUNT has proven to be a valuable technical tool for quantifying Legionella in various water matrices.
Segmentation: Legionella Testing Market Report 2023 - 2034
Legionella Testing Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Mn)
- IVD Testing
- Water Testing
Legionella Testing Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- Direct Fluorescent Antibody (DFA) Stain
- PCR
- Microbial Culture
- Others
- Serotyping
Legionella Testing Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Legionella Testing Market: Type Estimates & Trend Analysis
8. Legionella Testing Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Legionella Testing Market
11. Europe Global Legionella Testing Market
12. Asia Pacific Global Legionella Testing Market
13. Latin America Global Legionella Testing Market
14. MEA Global Legionella Testing Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Pro Lab Diagnostics Inc.
- Abbott
- BIOMÉRIEUX
- QIAGEN
- BD
- Hologic Inc.
- Bio-Rad Laboratories Inc.
- Eiken Chemical Co. Ltd.
- Thermo Fisher Scientific Inc.
- Takara Bio Inc.
- F. Hoffmann-La Roche Ltd.
- Beckman Coulter Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 263.1 Million |
| Forecasted Market Value ( USD | $ 644.7 Million |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
